What were Amanta Healthcare Ltd's latest quarterly results?
Amanta Healthcare Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: -7.2% (inflecting downward)
- Revenue Growth YoY: +6.8%
- Operating Margin: 19.4% (volatile)
In , Amanta Healthcare Ltd (Pharmaceuticals Bulk Drugs & Formulation) is outperforming Nifty 500 with +55.2% relative strength. Fundamentals: Weak. On a 4-week streak.
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +7% | +4% | Inflection Up |
| PAT (Net Profit) | -7% | +80% | Inflection Down |
| OPM | 19.4% | -688 bps | Volatile |
Based on publicly available financial data. This is educational research, not investment advice.
Amanta Healthcare Ltd's latest quarterly results (Mar 2026) show
Amanta Healthcare Ltd's profit is declining with an inflecting downward trend.
Amanta Healthcare Ltd's revenue growth trend is turning around (inflection up).
Amanta Healthcare Ltd's operating margin is volatile.
Amanta Healthcare Ltd's long-term compounding rates
Amanta Healthcare Ltd's earnings growth is inflecting downward with mixed signals on a sequential basis.
Amanta Healthcare Ltd's trailing twelve month (TTM) performance
Amanta Healthcare Ltd appears fairly valued based on our fair value analysis.
Amanta Healthcare Ltd's current PE ratio is 42.3x.
Amanta Healthcare Ltd's current PE is 42.3x.
Amanta Healthcare Ltd's price-to-book ratio is 3.2x.
Amanta Healthcare Ltd is rated Weak with a fundamental score of 32.15/100. This score is calculated from objective financial metrics
Amanta Healthcare Ltd's debt position
Amanta Healthcare Ltd's return ratios over recent years
Amanta Healthcare Ltd's operating cash flow is positive (FY2026).
Amanta Healthcare Ltd currently does not pay a significant dividend (yield 0.00%).
Amanta Healthcare Ltd's shareholding pattern (Mar 2026)
Amanta Healthcare Ltd's promoter holding has increased recently.
Amanta Healthcare Ltd has been outperforming Nifty 500 for 4 consecutive weeks, indicating building momentum.
Amanta Healthcare Ltd is a re-entry — it briefly dropped off the outperformance list but has now returned. Re-entries can signal renewed strength.
Based on quantitative research signals, here is why Amanta Healthcare Ltd may be worth studying
Amanta Healthcare Ltd investment thesis summary:
Amanta Healthcare Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.